肿瘤资讯系统市场规模、份额和成长分析（按应用、产品/服务、最终用户和地区划分）—产业预测（2026-2033 年）

全球肿瘤资讯系统市场规模预计在 2024 年达到 77.8 亿美元，从 2025 年的 83.9 亿美元成长到 2033 年的 154.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.9%。

全球肿瘤资讯系统 (OIS) 市场正经历显着成长，这主要得益于医疗机构（包括医院和研究实验室）对高效能病患资料管理和治疗优化日益增长的需求。政府对肿瘤研究投入的不断增加，在这一市场扩张中发挥了关键作用。随着医疗服务提供者寻求先进的 OIS 软体解决方案，癌症治疗产业的创新和技术发展势头强劲。在医疗保健领域大量资金筹措的推动下，这为领先的 OIS 开发商创造了丰厚的投资机会。此外，OIS 透过提供全面及时的患者资讯来提高治疗效果，使临床医生能够制定精准的治疗方案，最终有助于提升整体医疗品质和患者预后。未来，对能够简化数据收集并支持临床决策的治疗计划系统的需求预计也将持续增长。

全球肿瘤资讯系统市场驱动因素

全球癌症发生率的不断攀升，推动了对肿瘤资讯系统的巨大需求。癌症仍然是全球首要死因，因此迫切需要高效的解决方案来改善治疗方案的製定、数据管理以及整体患者照护品质。肿瘤资讯系统在此背景下发挥关键作用，它能够实现即时资讯共用，并提高治疗过程的精准度。此外，药物治疗的进步也增强了这些系统的效用，有助于改善患者的治疗效果。这种不断变化的情况凸显了将先进技术融入肿瘤实践的重要性，以便更好地应对癌症治疗中日益严峻的挑战。

限制全球肿瘤资讯系统市场的因素

肿瘤资讯系统（OIS）广泛应用面临的主要挑战之一是其部署和维护带来的沉重经济负担。先进的OIS平台需要对基础设施、软体和培训人员进行大量投资，这使得小规模的医疗机构，尤其是在中低收入地区，难以负担。此外，持续的维护、软体更新和网路安全措施成本进一步加剧了经济负担，限制了资源匮乏地区该市场的成长潜力。这些经济限制阻碍了许多医疗机构有效利用先进的OIS技术。

全球肿瘤资讯系统市场趋势

全球肿瘤资讯系统 (OIS) 市场正日益受到人工智慧 (AI) 整合的影响，以提高治疗的精确度和营运效率。 AI 驱动的解决方案能够分析大量资料集，发现模式并预测患者对治疗的反应，从而最大限度地减少人为错误，加快决策速度，即使在复杂情况下也能如此。这一趋势反映了肿瘤治疗正朝着更个人化的方向发展，迫使各公司投资于 AI 增强功能，以实现产品差异化，并满足对创新癌症治疗解决方案日益增长的需求。随着市场的演变，AI 在塑造肿瘤管理系统的未来方面正发挥着至关重要的作用。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 专利分析

全球肿瘤资讯系统市场规模（依产品及服务划分）及复合年增长率（2026-2033 年）

• 软体
  • 病患资讯系统
  • 辐射资讯系统
  • 肿瘤电子健康记录（EHR）
  • 实验室资讯系统
  • 化疗资讯系统
  • 治疗计划系统
  • 临床决策支援系统
  • 放射治疗计划系统
  • 近距离放射治疗计划系统
  • 治疗管理系统与医学影像分析系统
  • 人口健康管理
  • 临床整合解决方案
  • 图片存檔与通讯系统（PACS）与视觉导航（VNA）
  • 先进的可视化和图像分析解决方案
  • 辐射剂量管理解决方案
• 专业服务
  • 咨询/优化服务
  • 实施服务
  • 售后及维护服务

全球肿瘤资讯系统市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 放射肿瘤学
• 肿瘤内科
• 外科肿瘤学

全球肿瘤资讯系统市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院和诊断影像中心
• 消融和癌症治疗中心
• 政府机构
• 研究设施

全球肿瘤资讯系统市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Elekta AB（Sweden）
• McKesson Corporation（United States）
• Siemens Healthineers（Germany）
• Epic Systems Corporation（United States）
• IBM Corporation（United States）
• Cerner Corporation（United States）
• Advanced Data Systems Corporation（United States）
• F. Hoffmann-La Roche AG（Switzerland）
• AmerisourceBergen Corporation（United States）
• General Electric Company（United States）
• Accuray Incorporated（United States）
• Optum, Inc.（United States）
• Allscripts Healthcare Solutions, Inc.（United States）
• MICA Information Systems, Inc.（United States）
• CureMD Healthcare（United States）
• EndoSoft LLC（United States）
• RaySearch Laboratories AB（Sweden）
• Altos Solutions（United States）
• Flatiron Health（United States）
• Bogardus Medical Systems（United States）

结论与建议

Global Oncology Information Systems Market size was valued at USD 7.78 Billion in 2024 and is poised to grow from USD 8.39 Billion in 2025 to USD 15.42 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

The Global Oncology Information Systems (OIS) market is experiencing significant growth driven by the rising demand for efficient patient data management and treatment optimization in healthcare settings, including hospitals and research labs. Increased government investment in oncology research plays a pivotal role in this market expansion. As healthcare providers seek advanced OIS software solutions, innovation and technology development in the cancer care industry are gaining momentum. This presents lucrative opportunities for investment in leading OIS developers, fueled by substantial funding in the healthcare sector. Furthermore, OIS enhances treatment effectiveness by ensuring timely delivery of comprehensive patient information, allowing clinicians to create precise treatment plans, thereby improving overall care quality and patient outcomes. The future will also see increased demand for medical planning systems that streamline data collection and assist in clinical decision-making.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Information Systems market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oncology Information Systems Market Segments Analysis

Global Oncology Information Systems Market is segmented by Product and Service, Application, End User and region. Based on Product and Service, the market is segmented into Software and Professional Services. Based on Application, the market is segmented into Radiation Oncology, Medical Oncology and Surgical Oncology. Based on End User, the market is segmented into Hospitals & Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions and Research Facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oncology Information Systems Market

The rising global incidence of cancer significantly propels the demand for oncology information systems. As cancer remains a leading cause of mortality worldwide, there is an urgent need for efficient solutions to enhance treatment planning, data management, and overall patient care. Oncology information systems play a crucial role in this landscape by enabling real-time information sharing, which enhances the precision of treatment processes. Furthermore, the effectiveness of these systems is amplified by advances in pharmaceutical treatments, contributing to improved patient outcomes. This evolving landscape underscores the importance of integrating advanced technologies into oncology practices to better address the growing challenges associated with cancer care.

Restraints in the Global Oncology Information Systems Market

A significant challenge hindering the widespread adoption of Oncology Information Systems (OIS) is the substantial financial burden associated with their implementation and upkeep. Advanced OIS platforms necessitate considerable investments in infrastructure, software, and trained personnel, making them unaffordable for smaller healthcare facilities, particularly in low- and middle-income regions. Additionally, the ongoing expenses related to maintenance, software updates, and cybersecurity measures further exacerbate the financial strain, limiting the growth potential of this market in areas with fewer resources. These economic constraints inhibit the ability of many healthcare providers to leverage advanced OIS technology effectively.

Market Trends of the Global Oncology Information Systems Market

The Global Oncology Information Systems (OIS) market is increasingly influenced by the integration of artificial intelligence (AI) to enhance treatment precision and operational efficiency. AI-driven solutions are capable of analyzing extensive datasets to uncover patterns and predict patient responses to therapies, thereby minimizing human error and expediting decision-making, even in complex scenarios. This trend reflects a shift towards more personalized oncology care, compelling companies to invest in AI-enhanced functionalities to differentiate their offerings and cater to the rising demand for innovative cancer treatment solutions. As the market evolves, AI's role is becoming pivotal in shaping the future of oncology management systems.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Patent Analysis

Global Oncology Information Systems Market Size by Product and Service & CAGR (2026-2033)

• Market Overview
• Software
  • Patient Information Systems
  • Radiology Information Systems
  • Oncology Electronic Medical Record (EHR)
  • Laboratory Information Systems
  • Chemotherapy Information System
  • Treatment Planning Systems
  • Clinical Decision Support Systems
  • Radiotherapy Treatment Planning Systems
  • Brachytherapy Treatment Planning Systems
  • Treatment Management Systems & Medical Image Analysis Systems
  • Population Health Management
  • Clinical Integration Solutions
  • Picture Archiving and Communication System (PACS) & VNA
  • Advanced Visualization & Image Analysis Solutions
  • Radiation Dose Management Solutions
• Professional Services
  • Consulting/Optimization Services
  • Implementation Services
  • Post-Sale and Maintenance Services

Global Oncology Information Systems Market Size by Application & CAGR (2026-2033)

• Market Overview
• Radiation Oncology
• Medical Oncology
• Surgical Oncology

Global Oncology Information Systems Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals & Diagnostic Imaging Centers
• Ablation Care Centers and Cancer Care Centers
• Government Institutions
• Research Facilities

Global Oncology Information Systems Market Size & CAGR (2026-2033)

• North America (Product and Service, Application, End User)
  • US
  • Canada
• Europe (Product and Service, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product and Service, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product and Service, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product and Service, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Data Systems Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accuray Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optum, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MICA Information Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CureMD Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EndoSoft LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RaySearch Laboratories AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altos Solutions (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bogardus Medical Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations